bupropion has been researched along with Gelineau Syndrome in 1 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rye, DB | 1 |
| Dihenia, B | 1 |
| Bliwise, DL | 1 |
1 other study available for bupropion and Gelineau Syndrome
| Article | Year |
|---|---|
Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder; Dopamine; Female; Humans; | 1998 |